Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7303 p732
12 June 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacists’ chronic disease role recognised

Community pharmacists in England give the NHS a head start in managing chronic illness. So says a Department of Health guide to chronic disease management published last month.

“Chronic disease management: a compendium of information” lists pharmacists as one of the main providers of chronic disease care in primary care. It adds that the new pharmacy contract, which has yet to be agreed by the Pharmaceutical Services Negotiating Committee and the DoH, will allow primary care trusts to broaden the services that are available in the community.

National Pharmaceutical Association chief executive John D’Arcy said: “We are delighted that the message is getting through. Managing chronic disease is primarily a community-based activity, aimed at reducing the need for expensive secondary care interventions that deal with the consequences of poorly controlled conditions.”

He added that many hospital admissions are due to older people’s inability to manage drug therapy. “Half of all people with chronic conditions fail to take their medicines properly, so effective chronic disease management needs to involve a more pronounced effort to improve medicines use. Community pharmacist-led medicines management may soon become widespread, with the inclusion of medicines use review as an advanced service in the proposed new national community pharmacy contract providing a stepping stone.”

The guide is available here

Back to Top


©The Pharmaceutical Journal